An expert in oversight and execution of molecular Clinical Trial Testing under GxP, GMP, GLP guidelines with rigorous Quality Systems programs. Deep understanding of NGS methodologies and data analysis focused on endpoint characterization of human genome and microbiome profiling. Extensive proficiency in assay development and analytical/clinical validation centered on the commercial launch of NGS assays in CAP/CLIA certified laboratories.